Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesorectal Excision With Lateral Lymph Node Dissection Versus Without Lateral Lymph Node Dissection for Clinical Stage II, III Lower Rectal Cancer (JCOG0212)

NCT00190541 is registered in ClinicalTrials.gov with Haruhiko Fukuda as lead sponsor.

NCT NCT00190541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00190541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesorectal Excision With Lateral Lymph Node Dissection Versus Without Lateral Lymph Node Dissection for Clinical Stage II, III Lower Rectal Cancer (JCOG0212)
Lead sponsor
Haruhiko Fukuda
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2003
Completion date
June 30, 2015
Enrollment
700 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

rectal neoplasms